Oxygen Partition Between Microvessels and Tissue: Significance for the Design of Blood Substitutes
Amy G. Tsai
1, Barbara Friesenecker
2, and Marcos Intaglietta
1Summary. Correction of blood losses with blood substitutes alter the pO
2distribution in the microcirculation, with outcomes depending on the final viscosity of the circulating blood and the vasoactivity induced to the restore normal distribution of pO
2. Vasoactivity has an oxygen cost shown by the oxygen consumption of the arteriolar microcirculation. Vasodilators lower arteriolar oxygen consumption delivering more oxygen to the tissues, and vice versa. Increased oxygen delivery to the arterioles by right shifted oxygen dis- sociation causes autoregulatory vasoconstriction, a problem aggravated by low blood and plasma viscosity that lowers NO endothelial NO production.
Restoration of tissue function is achieved when no portion of the tissue falls below the threshold of anaerobic metabolism. This goal is attained by using high affinity modified hemoglobins that act as a reservoir of oxygen only deployed when the circulating blood arrives at tissue regions where pO
2is very low. Given these premises, restoration of tissue function after severe blood losses requires the re-establishment of oxygen delivery capacity and pO
2distribution. This is attained by tailoring blood and plasma viscosity and oxygen dissociation properties to insure that no portion of the tissue lacks oxygen delivery, even though overall tissue pO
2may be abnormally low.
Key words. Vessel wall oxygen consumption, Tissue oxygenation, Oxygen delivery
70
1Department of Bioengineering, 0412, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0412, USA
2Division of General and Surgical Intensive Care Medicine, Department of Anesthesia and Critical Care Medicine, The Leopold-Franzens-University of Innsbruck, Austria
Introduction
The classical scheme for tissue oxygenation assumes that oxygen gathered by the lung capillaries from the atmosphere is distributed by the systemic cir- culation to the tissue capillaries, which yield their oxygen by being in close proximity with virtually every cell of the organism. In this process the lung capillaries receive oxygen that diffuses through a high oxygen concentration gradient, while tissue capillaries deliver oxygen by means of a low concen- tration gradient, a situation rendered possible because of the large surface area disparity between tissue and lung capillaries, which is about a factor of 10 ¥.
While the capillaries are in virtual equilibrium with tissue, there is also a large disparity between arterial and tissue pO
2, which indicates that there is a significant oxygen loss from blood as it transits from the lungs to the tissue.
This oxygen loss determines a longitudinal oxygen gradient mostly devel- oped in the microcirculation, leading to a specific distribution of intravascu- lar oxygen tension. There is substantial evidence that the circulation is adapted to this distribution and that the organism strives to maintain this specific pattern by the process of autoregulation [1,2].
Local autoregulation is based on arteriolar vasoactivity, a process that engages the smooth muscle of the arteriolar wall leading to vasodilation and vasoconstriction, and the control of blood flow which regulates oxygen deliv- ery to counteract the changes in intravascular oxygen distribution.
The Oxygen Cost of Blood Flow Regulation
Arterioles yield a significant amount of the oxygen that they carry directly to the tissue, instead of delivering this to the capillary system (leading to the presence of an intraluminal, longitudinal oxygen gradient), therefore in prin- ciple these microvessels should be a major source of oxygen for the tissue.
Mass balance analysis of the rate of exit of oxygen from arteriolar segments showed that it was much greater than that solely accounted by the process of diffusion, leading to the proposal that the diffusion constant of the arteriolar wall was of the order of 10¥ of that of normal tissue [3], a process for which there is no physical evidence.
An alternative explanation is that the vessels wall is a large oxygen sink due
to the high metabolic activity of the endothelium and possibly smooth muscle
in vivo and in situ. The presence of such an oxygen sink was demonstrated
by the measurements of Tsai et al. [4], who found large pO
2gradients in the
region of the vessel wall, a finding that was recently confirmed by Shibata
et al. [5]. In this situation large oxygen gradients can also be due to a large resistance to oxygen exit, however this alternative is not compatible with the measured large rates of oxygen exit measured from arterioles.
Arteriolar wall oxygen consumption is not a static, fixed rate, and it varies in accordance to microvessels tone or level of vasoconstriction. Under normal conditions 50 mm diameter arterioles of the unanesthetized hamster window chamber preparation consume about 25% of the oxygen convected by the blood stream, a rate that is evidenced by the these vessels exhibiting a vessel wall gradient, i.e., difference between in pO
2across the vessel wall, of 18 .5 mmHg. The continuous infusion of PGE
1(2.5 mg/kg min, i.v.) was found to increase flow by a factor of 2.18x and lower the vessel wall oxygen gradi- ent to 15.5 mmHg. Geometrical considerations indicate that the oxygen gra- dient in 50 mm arterioles is 12 mmHg, the excess pO
2difference being attributed to vessels wall oxygen consumption. The same analysis shows that the oxygen gradient of the vessels wall [6] is linearly related to its rate of oxygen consumption, thus the decrease due to PGE
1halves vessel wall oxygen consumption. Not unexpectedly, the increased flow and lowered vessels wall oxygen consumption causes tissue pO
2to be 31.9 mmHg, vs. 24.5 mmHg found for normal conditions. The infusion of Vasopressin (0.001 IU/kg min i.v.) a vasoconstrictor, caused flow to decrease to 0.60 of control, increased the vessel wall oxygen gradient to 31.2 mmHg, and lowered tissue pO
2to 9.5 mmHg.
Similar findings have been reported by Ye et al. [7], who measured oxygen extraction from various tissues under different levels of tone.
The Significance of Tissue pO
2Tissue pO
2is controlled simultaneously by the rate at which oxygen is deliv-
ered by convection to the microcirculation and the rate that it is consumed
by the vessels walls, however the actual level of tissue pO
2is only indicative
of tissue oxygen supply, a factor that is significantly influenced by the shape
of the oxygen dissociation curve of hemoglobin, and therefore the intralumi-
nal distribution of oxygen in the microcirculation. In the normal hamster
window chamber model large arterioles and venules have respectively 56 and
33 mmHg blood oxygen partial pressure which corresponds to an arterio-
lar/venular difference in oxygen saturation of 34%, leading to a tissue pO
2of
24 .5 ± 5.0 mmHg (mean ± SD) according to Intaglietta et al. [8]. By compari-
son, if tissue were regulated at the verge of the transition of tissue hypoxia,
or about 2 mmHg, the threshold for anaerobic metabolism, and all intravas-
cular pO
2values were decreased by 22.5 mmHg the arteriolar/venular satura-
tion difference would by 45%, thus if blood flow were the same, the tissue
would receive more oxygen.
Normal tissue pO
2is regulated at a level that is significantly higher than that associated with anaerobic metabolism, which commences at pO
2s lower than about 2 mmHg [9]. The disparity between level of regulation and limit of oxidative metabolism can be explained by considering a hypothetical situation in which the tissue is regulated at 7 mmHg pO
2, under otherwise identical anatomical and microhemodynamic conditions. In this form of reg- ulation, if the pO
2variability remains the same, 16% of the tissue would be beyond the anaerobic threshold, i.e., beyond one standard deviation or 1s. It is apparent that regulating tissue at 24.5 mmHg places 99.98% of the tissue within the aerobic metabolism, the anaerobic portion being beyond 4s.
Oxygen Distribution in the Design of Blood Substitutes
To the present, blood substitutes have been mostly formulated using hemo- globin as the oxygen carrier. Formulations based on human hemoglobin must in principle provide a material that is as plentiful an efficacious as the natural blood, namely should be the result of a process that increase, or at least is equal to the amount of human blood utilized. In other words a practical product should yield an equivalent unit of blood utilizing at most a unit of natural blood. Formulations that use non-human hemoglobin or recombinant hemoglobin are not exempt from considerations of economy of oxygen carrier, since they are costly to produce.
An economic product can in principle be formulated if the material is vasoinactive and is utilized in minimal concentrations. However, overall hemoglobin concentrations (red blood hemoglobin plus product hemoglo- bin) that are significantly lower than that of natural blood will correspond- ingly significantly lower tissue pO
2placing substantial portions of the tissue in conditions of anaerobic metabolism, as shown in our previous example.
The statistical nature of oxygen distribution, however, indicates that even at low tissue pO
2conditions there are parts of the tissue whose pO
2is higher than the tissue average, therefore a solution of this problem is to introduce an oxygen reservoir that is only deployed for tissue regions at very low pO
2s.
This is readily accomplished by utilizing an oxygen carrier whose equivalent p50 is very low, i.e., a material that releases oxygen only in anoxic regions.
This analysis also shows that this approach is only possible if the material is
vasoinactive, otherwise the comparatively small amounts of oxygen trans-
ported by the low concentration formulation is utilized by the energy
requirements of vasoconstriction. Parenthetically and additional advantage
of oxygenating the tissue at low pO
2is that vessel wall oxygen consumption
is proportional to blood pO
2[6], thus less oxygen would be consumed by the
arteriolar walls.
These concepts have been validated by the experiments of Sakai et al., 1999 [10], who tested tissue oxygenation by hemoglobin vesicles formulated at varying p50s in a hemodilution protocol in hamster and determined that for this type of oxygen carrier optimal performance was attained at p50 = 16 mmHg vs. p50 = 36 mmHg for hamster blood. A material incorporating these features, namely vasoinactivity, low p50, i.e., 5 mmHg, and formulated at 4% hemoglobin concentration (MalPEG-hemoglobin, Hemospan) is presently produced by Sangart Inc, San Diego, has shown to be highly effica- cious in experimental studies [11] and is presently in clinical trials.
Acknowledgments. This work was supported by Bioengineering Research Partnership grant R24-HL 64395 and the grants R01-HL 62318 and R01-HL 62354 .
References
1. Johnson PC (1986) Brief Review: Autoregulation of blood flow, Circ Res 59:483–495 2. Duling BR, Berne RM (1970) Longitudinal gradients in periarteriolar oxygen tension.
A possible mechanism for the participation of oxygen in the local regulation of blood flow. Circ Res 27:669–678
3. Popel AS, Pittman RN, Ellsworth ML (1988) Rate of oxygen loss from arterioles is an order of magnitude than expected. Am J Physiol Heart Circ Physiol 256:H921–
H924
4. Tsai AG, Friesenecker B, Mazzoni MC, Kerger H, Buerk DG, Johnson PC, Intaglietta M (1998) Microvascular and tissue oxygen gradients in the rat mesentery. Proc Nat Acad Sci USA 95:6590–6595
5. Shibata M, Ichioka S, Ando J, Kamiya A (2001) Microvascular and interstitial pO2
measurements in rat skeletal muscle by phosphorescence quenching J Appl Physiol 91:321–327
6. Tsai AG, Johnson PC, Intaglietta M (2003) Oxygen gradients in the microcirculation.
Physiol Rev 83:933–963
7. Ye JM, Colquhoun EQ, Clark MG (1990) A comparison of vasopressin and noradren- aline on oxygen uptake by perfused rat hind limb, intestine, and mesenteric arcade suggests that it is part due to contractile work by blood vessels. Gen Pharmacol 21:805–810
8. Intaglietta M, Johnson PC, Winslow RM (1996) Microvascular and tissue oxygen dis- tribution. Cardiovasc Res 32:632–643
9. Richmond KN, Shonat RD, Lynch RM, Johnson PC (1999) Critical pO2of skeletal muscle in vivo. Am J Physiol Heart Circ Physiol 277:H1831–H1840
10. Sakai H, Tsai AG, Rohlfs RJ, Hara H, Takeoka S, Tsuchida E, Intaglietta M (1999) Microvascular responses to hemodilution with Hb vesicles as red blood cell substi- tutes: influence of O2affinity. Am J Physiol Heart Circ Physiol 276:H553–H562 11. Winslow RM, Gonzales A, Gonzales ML, Magde M, McCarthy M, Rohlfs RJ, Vandegriff
KD (1998) Vascular resistance and the efficacy of red cell substitutes in a rat hemor- rhage model. J Appl Physiol 85:993–1003